8-K: Kenvue Announces Q1 2025 Results and CFO Transition

Kenvue reports a slight decrease in net sales for Q1 2025, appoints Amit Banati as CFO, and updates its full-year outlook to reflect tariff costs and currency impacts.

Summary

• Kenvue's net sales decreased by 3.9% in Q1 2025 compared to the prior year, with organic sales declining by 1.2% due to unfavorable value realization and volume decline.
• The company's gross profit margin increased slightly to 58.0%, while adjusted gross profit margin decreased to 60.0%.
• Diluted earnings per share increased to $0.17, but adjusted diluted earnings per share decreased to $0.24.
• Kenvue has updated its full-year 2025 outlook, projecting a net sales increase of +1% to +3% and organic sales growth of +2% to +4%.
• The company announced the appointment of Amit Banati as CFO, effective May 12, 2025, succeeding Paul Ruh.
• Mr. Banati's compensation includes a base salary of $900,000, a bonus target of 110% of his base salary, and equity award grants with a target value of $3.2 million.
• He will also receive sign-on bonuses and equity awards contingent on the closing of the merger transaction between Mars Inc. and Kellanova.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the Q1 results show some declines, the appointment of a new CFO and the focus on future growth initiatives provide a balanced outlook.

Positives

• Gross profit margin expanded 40 basis points to 58.0%.
• Operating income margin increased to 14.9% from 14.1% in the prior year period.
• The company successfully completed Transition Services Agreement (TSA) exits in April.
• Diluted earnings per share increased to $0.17 vs $0.15 in the prior year period.

Negatives

• Net sales decreased by 3.9% year-over-year.
• Organic sales declined by 1.2% due to unfavorable value realization and volume decline.
• Adjusted gross profit margin declined 20 basis points to 60.0%.
• Adjusted operating income margin decreased from 22.0% to 19.8%.
• Adjusted diluted earnings per share decreased to $0.24 from $0.28 in the prior year period.

Risks

• The company faces headwinds from foreign currency translation, estimated at ~1% for the full year.
• Tariffs are expected to negatively impact the adjusted operating income margin.
• The company acknowledges the evolving macro and consumer environment presents ongoing challenges.
• The inability to execute on Kenvue's business development strategy.

Future Outlook

Kenvue expects a net sales increase of +1% to +3% year-over-year, with organic sales growth of +2% to +4% for full-year 2025, but anticipates a decline in adjusted operating income margin due to tariffs and a low-single-digit unfavorable impact from foreign currency on adjusted diluted earnings per share.

Management Comments

• Thibaut Mongon, CEO, stated that the company is committed to activating its brands while staying agile and flexible to accelerate sustainable profitable growth.
• Amit Banati, incoming CFO, said his focus will be supporting revenue growth, driving margin and cost profile improvement, strengthening cash flow, and fostering greater agility.

Industry Context

Kenvue, as the world's largest pure-play consumer health company, is navigating a challenging macro and consumer environment, similar to other companies in the consumer goods sector. The CFO transition suggests a strategic shift towards optimizing financial performance and driving growth.

Comparison to Industry Standards

• Kenvue's organic sales decline of 1.2% is a key metric to compare against peers like Procter & Gamble (PG), Unilever (UL), and Colgate-Palmolive (CL), which also operate in the consumer health space.
• The adjusted operating income margin of 19.8% can be benchmarked against the operating margins of these competitors to assess Kenvue's profitability.
• The company's focus on cost optimization and supply chain initiatives aligns with industry trends aimed at improving efficiency and profitability.
• Amit Banati's experience at Kellanova, Kraft Foods, Cadbury Schweppes and Procter & Gamble brings a wealth of knowledge in consumer products finance and operations, which is valuable for Kenvue's strategic direction.

Management Changes

Stakeholder Impact

• Shareholders can expect a focus on profitable growth and value delivery with the new CFO appointment.
• Employees may experience changes related to the company's restructuring and cost-saving initiatives.
• Customers may see continued investment in brands and product innovation.
• Suppliers could be affected by the company's supply chain optimization efforts.

Next Steps

• Amit Banati will assume the role of CFO on May 12, 2025.
• The company will continue to focus on accelerating profitable growth and optimizing its cost structure.
• Kenvue will work to mitigate the financial impact of tariffs through various actions.

Key Dates

Keywords

Kenvue, Financial Results, CFO, Amit Banati, Paul Ruh, Net Sales, Organic Sales, Earnings, Consumer Health, Transition